A 12-month clinical study of LA-2585 (45.0 mg): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancer (Q46890166)
Jump to navigation
Jump to search
scientific article published in February 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 12-month clinical study of LA-2585 (45.0 mg): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancer |
scientific article published in February 2006 |
Statements
1 reference
A 12-month clinical study of LA-2585 (45.0 mg): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancer (English)
1 reference
E David Crawford
1 reference
Oliver Sartor
1 reference
Franklin Chu
1 reference
Ramon Perez
1 reference
Gary Karlin
1 reference
J Steve Garrett
1 reference
1 February 2006
1 reference
1 reference
175
1 reference
2
1 reference
533-536
1 reference
Identifiers
1 reference
1 reference